Health

Dean Ornish, MD, believes that an intensive lifestyle intervention could potentially slow down the progression of early Alzheimer’s disease. This is a groundbreaking approach that challenges traditional methods of treatment for the condition. However, while the idea of “good” side effects is promising, it is important to approach such interventions with caution and further research
0 Comments
In a recent study presented at the European Alliance of Associations for Rheumatology (EULAR) annual meeting, the efficacy of patient-initiated follow-up contacts versus clinician-monitored follow-up for patients with axial spondyloarthritis (axSpA) was examined. This study, conducted by Inger Jorid Berg, MD, PhD, emphasized the potential benefits of letting patients take the lead in managing their
0 Comments
Air pollution is a growing concern not only for the environment but also for human health, especially for pregnant women. Recent studies have brought to light the troubling connection between maternal exposure to particulate matter (PM) and adverse outcomes during pregnancy, particularly relating to blood pressure issues. It is crucial to address this hidden risk
0 Comments
The advancement in research for the treatment of EGFR-mutant non-small cell lung cancer is crucial in improving patient outcomes. In a recent study conducted by Erminia Massarelli, MD, PhD, the combination of osimertinib and consolidative stereotactic ablative radiation (SABR) showed promising results. The study involved 43 patients with untreated EGFR-mutant non-small cell lung cancer with
0 Comments
The translation of pediatric discharge instructions is a critical aspect of healthcare, ensuring that patients and their families receive accurate and understandable information regarding follow-up care and medication recommendations. A recent study compared the performance of professional translations, Google Translate, and ChatGPT in translating instructions from English into Spanish, Brazilian Portuguese, and Haitian Creole. The
0 Comments
The recent unanimous support from the FDA advisory committee for the investigational drug donanemab in the treatment of early Alzheimer’s disease has brought new hope to patients with mild cognitive impairment and mild dementia. In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee concluded that the benefits of donanemab outweighed its
0 Comments
Rep. Jamie Raskin (D-Md.) expressed his opinion that Dr. Anthony Fauci is not a comic book super-villain amidst the House subcommittee investigation on COVID-19’s origins. This highlights the challenges faced by healthcare professionals during the pandemic. Dr. Jason Liebowitz from Columbia University shared his experience of feeling replaceable in the eyes of his employer after
0 Comments
Tirzepatide, a weight loss and diabetes drug, has shown promising results in treating Metabolic Dysfunction Associated Steatohepatitis (MASH) in a phase II study called SYNERGY-NASH. The study, presented by Dr. Rohit Loomba at the European Association for the Study of the Liver annual meeting, demonstrated significant resolution of MASH and liver fibrosis in participants receiving
0 Comments